PR Newswire Asia's news > Health Care/Hospital

 < Previous page   |   Title only   |   Print    Next page > 
     
Elixiron Immunotherapeutics Reports Positive Phase 2 Interim Results for Enrupatinib: Evidence of Neuroinflammation Reduction and Early Cognitive Benefit in Alzheimer's Disease
CAMBRIDGE, Mass. and TAIPEI , June 11, 2026 /PRNewswire/ -- Elixiron Immunotherapeutics (TPEx: 7871), a clinical-stage biopharmaceutical company pioneering precision immunotherapy for neurodegenerative ...
2026-06-11T    Health Care/Hospital   Medical/Pharmaceuticals 
Harbour BioMed Appoints Dr. Luisa Salter-Cid as Scientific Advisor
CAMBRIDGE, Mass., ROTTERDAM, Netherlands and SHANGHAI , June 11, 2026 /PRNewswire/ -- Harbour BioMed (the "Company"; HKEX: 02142), a global biopharmaceutical company committed to the discovery ...
2026-06-11T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
Pantai Hospital Kuala Lumpur Launches AI-Powered Adaptive Radiotherapy System to Advance Personalised Cancer Care in Malaysia
Varian Ethos with HyperSight supports daily treatment adaptation, helping clinicians deliver more precise radiotherapy while reducing unnecessary exposure to healthy tissue  ...
2026-06-11T    Health Care/Hospital   Medical Equipment   Medical/Pharmaceuticals 
ToolGen Opens Advanced Field Testing Facility in Osong, Completing 'Bench-to-Field' Commercialization Platform for Global SAF and Industrial Crop Markets
Establishes a regulatory-compliant, state-of-the-art Genome-Edited (GE) Crop Field Testing Facility to accelerate global commercialization. Enables comprehensive field evaluation of a diversified ...
2026-06-11T    Agriculture   Biotechnology   Health Care/Hospital 
Frost & Sullivan: Global Pharmaceutical Industry Faces a High-Stakes Reset as AI, Biologics, and Supply Resilience Redefine Growth Through 2031
New Frost & Sullivan analysis reveals that future winners will be those that can execute faster, industrialise innovation, and navigate mounting pricing and geopolitical pressures ...
2026-06-11T    Health Care/Hospital   Medical/Pharmaceuticals 
MINISH USA Showcases Pioneering Minimally Invasive Dental Innovations at CDA Presents 2026 in Anaheim
LOS ANGELES , June 10, 2026 /PRNewswire/ -- MINISH USA, a rising global leader in advanced medtech and biomimetic tooth restoration, announced today its highly successful return to the California Dental ...
2026-06-10T    Health Care/Hospital   Trade show news 
HkeyBio Launches "NHP Fast-PoC" Program to Deliver Low-Cost Cyno PK/PD and Developability Data Amid Rising NHP Prices
The cost-effective platform delivers rapid pharmacological validation data in cynomolgus monkeys, helping biotech firms make confident R&D decisions before committing to full-scale IND studies. ...
2026-06-10T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
QingSong Health Corp (2661.HK) and Basel Medical Sign Strategic Cooperation Memorandum to Explore AI Healthcare Services in Southeast Asia
BEIJING , June 10, 2026 /PRNewswire/ -- Recently, QingSong Health Corp (2661.HK) and Basel Medical Group Ltd  announced the signing of a Memorandum of Strategic Cooperation. The two parties intend ...
2026-06-10T    Computer/Electronics   Health Care/Hospital   Medical Equipment   Medical/Pharmaceuticals 
Vatech Completes Full-Portfolio EU MDR Certification
Certification covers all three dental imaging categories and every 2026 model launch ...
2026-06-10T    Health Care/Hospital   Medical Equipment   Medical/Pharmaceuticals 
UndoAge and Novonesis Forge Strategic Partnership to Drive High-Quality Development of China's Probiotic Industry
Beijing , June 10, 2026 /PRNewswire/ -- UndoAge and Novonesis, a global biosolutions company backed by Novo Holdings, signed a Memorandum of Understanding (MOU) in Beijing on June 9 . The partnership ...
2026-06-10T    Biotechnology   Health Care/Hospital 
 < Previous page    Next page >

Mobile | Full
Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer | Site Map
Copyright (C) 2026 Suntek Computer Systems Limited. All rights reserved
Disclaimer : In the preparation of this website, 88iv endeavours to offer the most current, correct and clearly expressed information to the public. Nevertheless, inadvertent errors in information and in software may occur. In particular but without limiting anything here, 88iv disclaims any responsibility and accepts no liability (whether in tort, contract or otherwise) for any direct or indirect loss or damage arising from any inaccuracies, omissions or typographical errors that may be contained in this website. 88iv also does not warrant the accuracy, completeness, timeliness or fitness for purpose of the information contained in this website.